NYMOX PHARMACEUTICAL CORP Total Assets

Quick Answer

NYMOX PHARMACEUTICAL CORP reported Total Assets of $654.0 thousand for the year ending 2024.

  • NYMOX PHARMACEUTICAL CORP showed an increase of +4.3% in Total Assets from 2023 to 2024.
  • This data is from NYMOX PHARMACEUTICAL CORP's annual report (Form 10-K), filed with the SEC on June 3, 2025.
  • XBRL data for this metric is available from 2015 to 2024 (10 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
  • Over the full 10 years of available data (2015 to 2024), NYMOX PHARMACEUTICAL CORP's Total Assets has declined by 8.1%.
  • Historical annual values: Fiscal year 2024: $654.0 thousand | Fiscal year 2023: $627.0 thousand | Fiscal year 2022: $1.63 million | Fiscal year 2021: $1.44 million | Fiscal year 2020: $4.34 million | Fiscal year 2019: $5.49 million | Fiscal year 2018: $8.08 million | Fiscal year 2017: $979.0 thousand | Fiscal year 2016: $2.06 million | Fiscal year 2015: $712.0 thousand.
  • Data sourced from SEC EDGAR public filings as of August 6, 2026.

Last verified: